Search for: "Pfizer, Inc." Results 921 - 940 of 1,512
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Jun 2010, 6:09 am by Bob Kraft
The Food and Drug Administration said Monday Pfizer Inc. is withdrawing its cancer drug Mylotarg from the U.S. market after a clinical study showed the drug wasn't effective and had more safety problems. [read post]
27 Jun 2010, 5:22 am by Dr. Shezad Malik
Bloomberg News (6/18, Feeley) reported, "Pfizer Inc. faces a Texas trial over its hormone-replacement drugs after a court overseeing lawsuits over the medicines sent 200 cases back to their home courts. [read post]
24 Jun 2010, 5:00 am by Kimberly A. Kralowec
During its conference last week (on June 17, 2010), the Supreme Court denied review and depublication in the ninth post-Tobacco II case, Pfizer, Inc. [read post]
23 Jun 2010, 10:28 pm
(Patent Docs) (Patent Docs) Sutent (Sunitinib) - US: Patent infringement complaint following a Para IV certification: Pfizer Inc. et al. v. [read post]
22 Jun 2010, 12:41 pm by Erin Miller
Brief in opposition of respondents Independent Living Center of Southern California, Inc. et al. [read post]
22 Jun 2010, 10:10 am
Zambri, founding partner The Wall Street Journal (6/22, Dooren) reports that the FDA has announced that Pfizer Inc. has withdrawn Mylotarg (gemtuzumab ozogamicin) from the US market following research indicating that the medication was not effective and was linked to safety issues. [read post]
21 Jun 2010, 2:30 pm by Lucas A. Ferrara, Esq.
Market Pfizer Inc. today announced the voluntary withdrawal from the U.S. market of the drug Mylotarg (gemtuzumab ozogamicin) for patients with acute myeloid leukemia (AML), a bone marrow cancer. [read post]
21 Jun 2010, 11:46 am by Joe Consumer
Last Friday, a Javelin Pharmaceuticals, Inc. news release on Business Wire announced that the U.S. [read post]
21 Jun 2010, 9:57 am
Inc.), Merck Sharp & Dohme B.V. and Merck Sharp & Dohme is upon us. [read post]
21 Jun 2010, 7:12 am
Recently, the first trial date was set in a group of over 8,000 personal injury and product liability lawsuits pending against Pfizer, Inc., claiming its menopause drug Prempro is a defective and dangerous product because it has been linked to breast cancer. [read post]
20 Jun 2010, 8:51 pm by Patent Docs
Pfizer Inc. et al. v. [read post]
17 Jun 2010, 3:51 pm by Matt C. Bailey
On June 17, 2010, the California Supreme Court denied the petition for review and request for depublication in Pfizer, Inc. v. [read post]
14 Jun 2010, 3:58 am by Bob Kraft
Blue Cross Blue Shield of Texas, which is the largest health insurer in Texas, has filed suit in federal court in Texas against Pfizer Inc. for deceptive marketing of drugs and for illegal kickbacks to doctors. [read post]
12 Jun 2010, 9:01 am by Frank Pasquale
., Eli Lilly & Co. and Pfizer Inc., legally avoid some income taxes by converting sales in one country to profits in another — on paper only, and often in places where they have few employees or actual sales. . . . [read post]
10 Jun 2010, 6:25 am
Zambri, founding partner According to an AP report, the Food and Drug Administration issued a warning letter to "Pfizer Inc. for failing to promptly report complaints with its drugs that may have involved serious injury. [read post]
8 Jun 2010, 4:54 am by Mark Zamora
Image via WikipediaA strong public warning was issued Thursday about stop-smoking pill Champix by the drug-maker and federal health officials concerned over mounting reports of mood changes, hostility, suicidal behaviour and serious, sometimes fatal, skin reactions.Champix, the brand name of varenicline tartrate sold by Pfizer Canada Inc., must now carry a boxed warning, which is reserved for drugs that have been linked to serious safety issues or adverse events. [read post]
2 Jun 2010, 8:50 am
Kearney 74 KPMG LLP 75 Hewlett-Packard 76 Monitor Group 77 Cargill 78 Pfizer 79 Toyota Motor Sales, U.S.A. 80 BP 81 U.S. [read post]